Stanford University


Showing 591-600 of 1,220 Results

  • Clete A. Kushida, MD, PhD

    Clete A. Kushida, MD, PhD

    Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsDr. Kushida is a neurologist and sleep specialist who directs several NIH- and industry-sponsored research studies, focused on topics such as the physical features and neurocognitive changes associated with the obstructive sleep apnea syndrome, the epidemiology and treatment of restless legs syndrome/periodic limb movement disorder, primary care sleep education and training, and countermeasures for sleep loss.

  • Phillip Kyriakakis

    Phillip Kyriakakis

    Temp - Non-Exempt, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    BioPhillip Kyriakakis, Ph.D. is a Senior Research Scientist in the Bioengineering Department at Stanford University in the Wu Tsai Institute for Neuroscience. Dr. Kyriakakis did his undergraduate work in Biochemistry at UMass Boston, where he also worked in Dr. Alexey Veraksa's developmental biology lab and started to develop PhyB optogenetics in animal cells (2008). Dr. Kyriakakis continued his education at UC San Diego in the Division of Biological Sciences. There, he studied cellular programming and metabolism to obtain his degree with a specialization in Multiscale Biology. Dr. Kyriakakis did his postdoctoral work in the Bioengineering Department at UC San Diego with Todd Coleman, continuing the development of optogenetic tools and related technologies. In 2021 Dr. Kyriakakis moved to his Senior Research Scientist role at Stanford University in the Bioengineering Department at the Wu Tsai Institute for Neurosciences.

  • Sheila Lahijani, MD, FACLP

    Sheila Lahijani, MD, FACLP

    Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
    Clinical Professor (By courtesy), Medicine - Oncology

    BioDr. Lahijani is a Clinical Professor at Stanford University School of Medicine and a nationally recognized leader in psycho-oncology. With extensive training and expertise in internal medicine, psychiatry, and consultation-liaison psychiatry, she has made significant contributions to the integration of psychiatric care within oncological settings.

    Since her appointment at Stanford in 2015, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center, where she provides medical psychiatric consultation services and collaborates with interdisciplinary teams to enhance patient outcomes. In her capacity as Medical Director of the Stanford Cancer Center Psychosocial Oncology Program, a position she has held since 2019, she is responsible for the strategic development and implementation of comprehensive psychiatric services tailored to the unique needs of patients with cancer.

    Additionally, Dr. Lahijani serves as the Section Chief of Psycho-Oncology in the Division of Medical Psychiatry where she oversees psych-onc faculty development and leads the training of medical psychiatry fellows in psycho-oncology. She is the Faculty Director of the Psychosocial Oncology Clerkship for medical students. Dr. Lahijani also supervises advanced practice providers and behavioral health clinicians while working as an attending psychiatric oncologist to provide care for patients with complex medical and psychiatric comorbidities across all hematology and oncology services.

    Dr. Lahijani's academic credentials include her graduation from Brown Medical School, followed by the completion of a combined residency in Internal Medicine and Psychiatry at Rush University Medical Center. After completing residency, she practiced internal medicine and psychiatry with a focus on triple diagnosis (HIV, addiction medicine, mental health). She then further advanced through a Psychosomatic Medicine Fellowship at Northwestern University's Feinberg School of Medicine, during which time she received specialized training in psychiatric oncology at the Lurie Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.

    Her clinical expertise encompasses psychopharmacology and a range of treatment modalities, including Meaning Centered Psychotherapy and Dignity Therapy. Dr. Lahijani is committed to fostering relationship-centered skills and promoting provider wellness. As a faculty member of Advancing Communication Excellence at Stanford, she has led workshops designed to enhance communication competencies among faculty and staff.

    Dr. Lahijani's scholarly pursuits are at the intersection of medicine and psychiatry, with a particular emphasis on the neuropsychiatric sequelae of cancer treatment, innovations in care, and medical education. She is dedicated to the education and mentorship of trainees in Psychiatry, Internal Medicine, Hematology/Oncology, Neurology, Geriatric Psychiatry, Palliative Medicine, and Breast Surgery. Through her commitment to academic excellence, Dr. Lahijani plays a pivotal role in preparing the next generation of clinicians, educators and scientists to understand and adeptly navigate the intricate and multifaceted needs of patients and their caregivers, thereby promoting a comprehensive approach to medicine.